AnGes Starts Global Phase III Clinical Trials of Collategene(R) for Critical … – GlobeNewswire (press release) | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« Spread of multiple myeloma halted in mice: Novel approach now being tested in clinical trials

Angina symptoms linked with elevated risk for CV events in patients with … – Healio »

AnGes Starts Global Phase III Clinical Trials of Collategene(R) for Critical … – GlobeNewswire (press release)

October 10, 2014 by 2012pharmaceutical

TOKYO, Oct. 6, 2014 (GLOBE NEWSWIRE) — AnGes MG, Inc. (“AnGes”) announces that it has commenced the global phase III clinical trials of Collategene

Source: globenewswire.com

See on Scoop.it – Cardiovascular and vascular imaging

Posted in Uncategorized | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 9,308 other subscribers
Recent Posts
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: